Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure

Aug 18, 06:12 PM
Headliner
Share
Subscribe

LEO Pharma, BioMarin, OmniAb, and Chugai post a busy week of pharma dealmaking, RELEX's Rohit Tripathi weighs in on who ultimately pays for tariff-driven input costs, and Spherix Global Insights' Sybil Mead unpacks IRA-driven formulary pressure spreading across payer portfolios.

Share
Subscribe
Next
Pharmaceutical Executive Daily: Henlius and Sandoz Strike Collaboration Agreement
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Key Findings of the NIAGARA and HIMALAYA Trials
by Pharmaceutical Executive